Medication info
Depateriem Extended-Release Tablet 10/750 mg (Teneligliptin Hydrobromide Hydrate, Metformin Hydrochloride)

Depateriem Extended-Release Tablet 10/750 mg (Teneligliptin Hydrobromide Hydrate, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
IYON Pharmaceuticals Co., Ltd.
Appearance
Yellow oval-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201304 · Approved 2022.04.04 · Insurance code 658604710

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient’s current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who are unable to achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient’s current metformin dose. For patients switching to this medicine from concomitant therapy with teneligliptin and metformin, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When administered with a sulfonylurea, a reduction in the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Because any change may affect glycemic control, all changes in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
IYON Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication helps regulate blood sugar levels in patients with type 2 diabetes by using teneligliptin and metformin together. It is administered as an adjunct when dietary and exercise control is insufficient, aiding in stable management of blood sugar levels. This improves the blood glucose control of patients.

How to take

Adult dose

The dose of this medicine should be determined based on each patient’s current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who are unable to achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient’s current metformin dose. For patients switching to this medicine from concomitant therapy with teneligliptin and metformin, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When administered with a sulfonylurea, a reduction in the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Because any change may affect glycemic control, all changes in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is a diabetes treatment that helps control blood sugar. It is essential to ensure that kidney function is normal before using this medication. Patients with impaired kidney function or severe renal impairment should not use this medication. Additionally, patients with liver impairment, heart failure, acute myocardial infarction, severe infection, or traumatic conditions should avoid this medication. It is also advisable not to administer this medication to pregnant women or women who may become pregnant, as well as to patients who are malnourished or severely weakened. This medication can rarely cause a dangerous condition known as lactic acidosis, so if symptoms such as shortness of breath, muscle pain, abdominal pain, or weakness occur, it is vital to notify a doctor immediately. When used in conjunction with other diabetes medications or insulin, hypoglycemia may occur, hence patients should be aware of hypoglycemic symptoms and their management. Regular blood tests to monitor kidney function and vitamin B12 levels are essential while using this medication. If scheduled for tests using radioactive iodine contrast, this medication should be stopped 48 hours prior and resumed only after confirming normal kidney function following the tests. For patients undergoing major surgery, this medication should also be discontinued 48 hours before surgery, and should resume only after confirming kidney function recovery. Patients should avoid excessive alcohol intake while taking this medication, as alcohol may elevate the risk of side effects. If skin blisters or severe joint pain occur during the use of this medication, it is necessary to consult medical staff immediately, and discontinuation may be required. Elderly patients may experience decreased kidney function, thus requiring dosage adjustments and regular kidney function tests. During the course of taking this medication, it is critical to monitor for symptoms of hypoglycemia, lactic acidosis, and liver dysfunction, and to consult a doctor immediately if any abnormal symptoms appear.

Side effects

Severe lactic acidosis, hypoglycemia, constipation, intestinal obstruction, liver dysfunction, interstitial pneumonia, similar pemphigus, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyps, colonic polyps, duodenal ulcers, gastroesophageal reflux disease, diarrhea, decreased appetite, increased amylase, increased lipase, elevated AST (GOT), elevated ALT (GPT), elevated GGT, elevated ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, elevated CK (CPK), increased serum potassium levels, malaise, allergic rhinitis, increased serum uric acid, peripheral edema, shingles, limb pain, epigastric pain, gastritis, upper respiratory tract infection, tremors, headache, asthenia, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory tract infection, rhinitis, cold sweat, diabetic retinopathy, decreased vision, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, headache, diarrhea, chronic gastritis, irritable bowel syndrome, fatigue, cerebral infarction, hyperglycemia, liver biopsy, reduced neutrophil count, abnormal blood sugar, increased blood sugar, increased blood pressure, hepatic coma, lumbar spinal canal stenosis, intervertebral disc protrusion, intervertebral disc disorder, spinal ligament ossification, foraminal stenosis, rotator cuff syndrome, bladder mass, ureteral stones, urinary stones, coronary artery disease, unstable angina, gastroesophageal reflux disease, gastric polyps, gastritis, biliary obstruction, chronic cholecystitis, soft tissue inflammation, pneumonia, cataracts, depression, iliac artery stenosis, dizziness, benign prostatic hyperplasia, knee surgery, urticaria, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, angina, otalgia, iron deficiency anemia, food allergy, pressure ulcer, ovarian cyst, vulvar pruritus, menopausal symptoms, toxic hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid damage, ligament sprain, lip injury, contusion, vomiting, abdominal pain, gastrointestinal motility disorder, decreased gastrointestinal motility, enteritis, toothache, anal and rectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, dyspnea, exertional dyspnea, atelectasis, epistaxis, chest discomfort, fever, chills, systemic edema, injection site inflammation, increased blood creatinine, increased blood urea, anxiety disorder due to general medical condition, hearing loss, endolymphatic hydrops, blood and lymphatic system disorders, anemia, benign, malignant, and unspecified neoplasms (including cysts and polyps)

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air entry, ideally at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the drug's effectiveness.

Appearance and packaging

Appearance

Yellow oval-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.